Editor's Comment
STEM CELLS IN REGENERATIVE UROLOGY OF THE BLADDER
CARDIOVASCULAR RISK AND THE UROLOGICAL PATIENT
The second-line management of idiopathic overactive bladder: what is the place of sacral neuromodulation and botulinum toxin-A in contemporary practice?
Key targets of hormonal treatment of prostate cancer. Part 2: the androgen receptor and 5α-reductase
Does diabetes mellitus modify the association between 17q12 risk variant and prostate cancer aggressiveness?
The promiscuous receptor
Survival outcomes in men receiving androgen-deprivation therapy as primary or salvage treatment for localized or advanced prostate cancer: 20-year single-centre experience
Tumour length of the largest focus predicts prostate-specific antigen-based recurrence after radical prostatectomy in clinically localized prostate cancer
Differences among patients undergoing perineal or retropubic radical prostatectomy in pain and perioperative variables: a prospective study
Radical cystectomy for urothelial carcinoma of the bladder: an analysis of perioperative and survival outcome
Protodynamic therapy for bladder cancer: in vitro results of a novel treatment concept
Prostate-sparing cystectomy: long-term oncological results
Long-term effects of repeated intradetrusor botulinum neurotoxin A injections on detrusor function in patients with neurogenic bladder dysfunction
Recovery of erectile function after radical prostatectomy is quantitatively related to the response to intraoperative cavernous nerve stimulation
Pure ‘natural orifice transluminal endoscopic surgery’ for transvaginal nephrectomy in the porcine model
Xanthogranulomatous pyelonephritis: presentation and management in the era of laparoscopy
Laparoscopic simultaneous bilateral partial and total adrenalectomy: a longer follow-up
Laparoscopic vs open radical nephroureterectomy for upper urinary tract urothelial cancer: oncological outcomes and 5-year follow-up
Paediatric testicular cancer: an updated review of incidence and conditional survival from the Surveillance, Epidemiology and End Results database
Mouse orthotopic models for bladder cancer research
Longitudinal studies of time-dependent changes in both bladder and erectile function after streptozotocin-induced diabetes in Fischer 344 male rats
New drugs from old - revisited
Essentials of Paediatric Urology; Second Edition
KEY TARGETS OF HORMONE TREATMENT OF PROSTATE CANCER. PART I: THE ANDROGEN RECEPTOR AND STEROIDOGENIC PATHWAYS
PERIPROSTATIC NERVE BLOCK (PNB) ALONE VS PNB COMBINED WITH AN ANAESTHETIC-MYORELAXANT AGENT CREAM FOR PROSTATE BIOPSY: A PROSPECTIVE, RANDOMIZED DOUBLE-ARM STUDY
Primary closure of bladder exstrophy
Abbreviations
Diary
Levels of Evidence